Rudnicki Lab

Biography

Michael Rudnicki is a Senior Scientist and the Director of the Regenerative Medicine Program and the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute. He is Professor in the Department of Medicine at the University of Ottawa. Dr. Rudnicki is CEO and Scientific Director of the Canadian Stem Cell Network (SCN). Dr. Rudnicki’s achievements have been recognized by numerous honours including being named a Tier 1 Canada Research Chair, an International Research Scholar of the Howard Hughes Medical Institute for two consecutive terms, a Fellow of the Royal Society of Canada, an Officer of the Order of Canada, and a Fellow of the Royal Society (London). He has been a founder in several spin-off biotechnology companies including Satellos Bioscience.

Dr. Rudnicki is an internationally recognized thought leader in molecular genetics and regenerative medicine whose research has transformed our understanding of muscle development and regeneration and has fueled the development of novel stem cell-based approaches to treat muscular dystrophy. His work is consistently published in top journals including Cell, Nature, Nature Cell Biology, Nature Medicine, and Cell Stem Cell. He holds major research grants from CIHR, NIH, SCN, and several health charities.

For the past 16 years, Dr. Rudnicki has led the Stem Cell Network (SCN), a transformative initiative involving over 175 investigators across Canada. As Scientific Director of the SCN, he has forged a national community that transformed stem cell research in Canada and brought research to the point where regenerative medicine is impacting clinical practice.